Clinical features and management of type I gastric carcinoids (Q38548932)

4 September 2017

1 reference

title

Clinical features and management of type I gastric carcinoids (English)

1 reference

4 September 2017

Yuichi Sato

1

1 reference

4 September 2017

publication date

17 September 2014

1 reference

Clinical journal of gastroenterology

4 September 2017

published in

1 reference

4 September 2017

volume

7

1 reference

4 September 2017

issue

5

1 reference

4 September 2017

page(s)

381-386

1 reference

One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States

4 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0528-9

Carcinoid tumors of the gastrointestinal tract: trends in incidence in England since 1971.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0528-9

A 50-year analysis of 562 gastric carcinoids: small tumor or larger problem?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0528-9

Review article: the investigation and management of gastric neuroendocrine tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0528-9

Classification, clinicopathologic features and treatment of gastric neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0528-9

Gastric carcinoids: between underestimation and overtreatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0528-9

Review of the pathogenesis, diagnosis, and management of type I gastric carcinoid tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0528-9

Current concepts in the diagnosis and management of type 1 gastric neuroendocrine neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0528-9

Neuroendocrine tumors of the stomach (gastric carcinoids) are on the rise: small tumors, small problems?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0528-9

Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0528-9

Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0528-9

Current Trends of the Incidence and Pathological Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) in Korea 2000-2009: Multicenter Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0528-9

The epidemiology of gastroenteropancreatic neuroendocrine tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0528-9

Clinical profiles, endoscopic and laboratory features and associated factors in patients with autoimmune gastritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0528-9

Mutations of RegIalpha are associated with enterochromaffin-like cell tumor development in patients with hypergastrinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0528-9

Gastrin increases mcl-1 expression in type I gastric carcinoid tumors and a gastric epithelial cell line that expresses the CCK-2 receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0528-9

Inappropriate hypergastrinaemia in asymptomatic healthy subjects infected with Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0528-9

Helicobacter pylori infection and chronic gastric acid hyposecretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0528-9

Antigastric autoantibodies in Helicobacter pylori infection: implications of histological and clinical parameters of gastritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0528-9

The gastric H+,K+-ATPase is a major autoantigen in chronic Helicobacter pylori gastritis with body mucosa atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0528-9

Helicobacter pylori lipopolysaccharide stimulates histamine release and DNA synthesis in rat enterochromaffin-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0528-9

Clinical symptoms, hormone profiles, treatment, and prognosis in patients with gastric carcinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0528-9

ENETS Consensus Guidelines for the management of patients with gastroduodenal neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0528-9

Gastric neuroendocrine neoplasms and related precursor lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0528-9

Histopathological classification of nonantral gastric endocrine growths in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0528-9

Standard imaging techniques for neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0528-9

Gastric and duodenal neuroendocrine tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0528-9

Tumor size and depth predict rate of lymph node metastasis and utilization of lymph node sampling in surgically managed gastric carcinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0528-9

Metastatic type 1 gastric carcinoid: a real threat or just a myth?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0528-9

The efficacy of endoscopic submucosal dissection of type I gastric carcinoid tumors compared with conventional endoscopic mucosal resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0528-9

Defining surgical indications for type I gastric carcinoid tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0528-9

Long-term follow-up of a large series of patients with type 1 gastric carcinoid tumors: data from a multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0528-9

Long-acting somatostatin analogues are an effective treatment for type 1 gastric carcinoid tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0528-9

Gastric endocrine tumors type I: treatment with long-acting somatostatin analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0528-9

Five-year follow-up of patients treated for 1 year with octreotide long-acting release for enterochromaffin-like cell carcinoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0528-9

Treatment of gastric carcinoids type 1 with the gastrin receptor antagonist netazepide (YF476) results in regression of tumours and normalisation of serum chromogranin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0528-9

Histologic characterization and improved prognostic evaluation of 209 gastric neuroendocrine neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0528-9

Accuracy of EUS in the evaluation of small gastric subepithelial lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12328-014-0528-9

Ability of somatostatin receptor scintigraphy to identify patients with gastric carcinoids: a prospective study

21 January 2018

1 reference

12 December 2020

Current concepts on gastric carcinoid tumors

1 reference

12 December 2020

Gastric carcinoid tumors: the biology and therapy of an enigmatic and controversial lesion

1 reference

12 December 2020

Endoscopic mucosal resection in the management of gastric carcinoid tumors

1 reference

12 December 2020

Usefulness of endoscopic submucosal dissection for type I gastric carcinoid tumors compared with endoscopic mucosal resection

1 reference

12 December 2020

Distinct patterns of chronic gastritis associated with carcinoid and cancer and their role in tumorigenesis

1 reference

12 December 2020

Long-term follow up of patients with multiple gastric carcinoids associated with type A gastritis

1 reference

12 December 2020

Antigenic mimicry between Helicobacter pylori and gastric mucosa in the pathogenesis of body atrophic gastritis

1 reference

12 December 2020

Gastric carcinoid tumors without autoimmune gastritis in Japan: a relationship with Helicobacter pylori infection

1 reference

12 December 2020

Loss of heterozygosity in 11q13-14 regions in gastric neuroendocrine tumors not associated with multiple endocrine neoplasia type 1 syndrome.

1 reference

12 December 2020

Neuroendocrine tumors

1 reference

12 December 2020

Long-term endoscopic and clinical follow-up of untreated type 1 gastric neuroendocrine tumours

1 reference

12 December 2020

How does Helicobacter pylori cause mucosal damage? Its effect on acid and gastrin physiology.

1 reference

12 December 2020

Management and clinical outcomes of type I gastric carcinoid patients: retrospective, multicenter study in Japan

1 reference

12 December 2020

Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: A clinicopathologic study

1 reference

12 December 2020

Microcarcinoid tumor diagnosed with high-resolution magnification endoscopy and narrow band imaging

1 reference

12 December 2020

Gastric carcinoids: biologic behavior and prognosis after differentiated treatment in relation to type

1 reference

12 December 2020

10.1007/S12328-014-0528-9

Identifiers

DOI

1 reference

Dimensions Publication ID

4 September 2017

1024872707

0 references

1 reference